retatrutide triple hormone receptor agonist metabolic obesity Media Centre Retatrutide Severe Obesity Trial Shows

The speed of appetite suppression varies based on your individual GLP-1 receptor sensitivity, starting dose, and metabolic state

M.CarrilhoE.et al

The reason for the initial elevated ratio is largely due to low creatinine (in 8/42 children), whereas none had high initial BUN values

The NOBILITY trial, a Phase II study, demonstrated that 35% of patients in the obinutuzumab group achieved Complete Renal Response (CRR) at week 52, compared to 23% in the placebo group, although this difference was not statistically significant (P = 0.115)

doi:10.1210/en.143.8.3152

This side effect can occur especially after meals or when taking a higher dose